Pharma

The startup, which also announced a $3.4 million raise, aims to collect longitudinal patient data for research.

PharmStars founder and CEO Naomi Fried talks about the company's call for applications to digital health companies that aim to improve women's health and health equity for underserved populations.

According to the study published in npj Digital Medicine, high scores for depressive symptoms and lower-than-excellent self-rated health were associated with less smartwatch use.

Elena Viboch, partner at General Catalyst, discusses her predictions for biotech and health tech investing and how startups can grow in a more constrained economic environment.

The consortium's collaboration and partnership opportunities may be the most beneficial to the HIMSS audience, according to James Hury, the Translational Research Institute for Space Health's chief innovation officer.

Drug development platform Quris raised another $9 million, and PharmStars is accepting applications for its accelerator cohort focused on women's health and health equity.

The Drug Enforcement Administration says the digital pharmacy wrongfully distributed thousands of prescription stimulants for ADHD, including Adderall.

The companies first partnered in 2020 to develop a prescription digital therapeutic for schizophrenia. They said a treatment strategy for the condition "would benefit from a multi-product approach."

According to TechCrunch and Fierce Healthcare, the health data company also recently closed a $200 million structured equity infusion.

The collaboration will offer low-cost medications to employees and employers through a new platform dubbed EmsanaRx Plus.